المؤلفون: Ruud L.M. Bekkers, Phyllis van der Ploeg, Sandrina Lambrechts, Jurgen M.J. Piek, Hans M. Westgeest, Anna M.J. Thijs, Aniek Uittenboogaard, Anja van de Stolpe, Ingrid A. Boere

المساهمون: RS: GROW - R2 - Basic and Translational Cancer Biology, Obstetrie & Gynaecologie, MUMC+: MA Medische Staf Obstetrie Gynaecologie (9)

المصدر: Gynecologic Oncology, 163(2), 433-444. Elsevier Science

مصطلحات موضوعية: Oncology, medicine.medical_treatment, MULTICENTER, Targeted therapy, Phosphatidylinositol 3-Kinases, Clinical endpoint, 1ST-IN-HUMAN, Phosphoinositide-3 Kinase Inhibitors, Ovarian Neoplasms, Mammalian target of rapamycin, PI3K PATHWAY, TOR Serine-Threonine Kinases, MTOR, Obstetrics and Gynecology, MTOR Inhibitors, Signal transduction pathway, Temsirolimus, Treatment Outcome, PHASE-I, ADVANCED SOLID TUMORS, Biomarker (medicine), Female, TRIAL, medicine.drug, Signal Transduction, EPITHELIAL OVARIAN, medicine.medical_specialty, Clinical Decision-Making, Antineoplastic Agents, SDG 3 - Good Health and Well-being, Predictive Value of Tests, Ovarian cancer, Internal medicine, medicine, Biomarkers, Tumor, Humans, DOSE-ESCALATION, Protein kinase B, PI3K/AKT/mTOR pathway, Neoplasm Staging, business.industry, Patient Selection, Akt, medicine.disease, Clinical trial, Phosphatidylinositol-3-kinase, TEMSIROLIMUS, business, Proto-Oncogene Proteins c-akt

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1d4a86c00b11c2413b6be3b738bbee7Test
https://doi.org/10.1016/j.ygyno.2021.07.008Test

المؤلفون: Holleh D Husseinzadeh, Nader Husseinzadeh

المصدر: Gynecologic Oncology. 133:375-381

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Uterine Cervical Neoplasms, Antineoplastic Agents, Growth inhibitory, Internal medicine, Gynecologic cancer, medicine, Humans, Everolimus, Protein kinase B, PI3K/AKT/mTOR pathway, Ovarian Neoplasms, Sirolimus, business.industry, TOR Serine-Threonine Kinases, Obstetrics and Gynecology, medicine.disease, Discovery and development of mTOR inhibitors, Endometrial Neoplasms, Clinical trial, Female, Ovarian cancer, business, Cell signaling pathways

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1818bb61e4d369c3d5f9dadc0e0661cTest
https://doi.org/10.1016/j.ygyno.2014.02.017Test

المؤلفون: D-A Silasi, Thomas J. Rutherford, Peter E. Schwartz, Masoud Azodi, Alessandro D. Santin, Maysa M. Abu-Khalaf, Lisa Baker, Martha A. Luther, K. ElSahwi, Elena Ratner

المصدر: Gynecologic Oncology. 120:S97-S98

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Everolimus, business.industry, Endometrial cancer, Obstetrics and Gynecology, Phases of clinical research, medicine.disease, Discovery and development of mTOR inhibitors, Internal medicine, Medicine, Topotecan, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::5475185ebb60f53f6fa126e0989d4fe7Test
https://doi.org/10.1016/j.ygyno.2010.12.232Test

المؤلفون: Jing Hu, Xiaobing Deng, E.A. Friedman, M.J. Cunningham

المصدر: Gynecologic Oncology. 133:82

مصطلحات موضوعية: medicine.medical_specialty, Kinase, business.industry, Obstetrics and Gynecology, Discovery and development of mTOR inhibitors, medicine.disease, Endocrinology, Oncology, Internal medicine, Ascites, medicine, Cancer research, medicine.symptom, business, Ovarian cancer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3b85e6546f269271f6e9a4d8f0c4b12eTest
https://doi.org/10.1016/j.ygyno.2014.03.220Test